FindMyKOL
Clinical trialNCT05276310RecruitingPhase 1Interventional

A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy

SponsorImmuneOncia Therapeutics Inc.Enrollment86Advanced Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is an Open-Label, Dose-Escalation and Expansion, Phase I Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of IMC-002 in Patients with Advanced Cancer Failed to Standard Therapy
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • National Cancer Center

    Goyang-si, South Korea

    Active, not recruiting
  • Asan Medical Center, Republic of Korea

    Seoul, South Korea

    Completed
  • Samsung Medical Center

    Seoul, South Korea

    Jung Yong Hong, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

IMC-002
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Jun 2022
Primary completion
30 Dec 2027
Completion
31 Aug 2030
Last update posted
25 Sept 2026
Registered enrollment
86
Registry id
NCT05276310
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.